0000046619-18-000031.txt : 20180320 0000046619-18-000031.hdr.sgml : 20180320 20180320144911 ACCESSION NUMBER: 0000046619-18-000031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180316 FILED AS OF DATE: 20180320 DATE AS OF CHANGE: 20180320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MENDELSON ERIC A CENTRAL INDEX KEY: 0001031083 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-04604 FILM NUMBER: 18701623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEICO CORP CENTRAL INDEX KEY: 0000046619 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT ENGINES & ENGINE PARTS [3724] IRS NUMBER: 650341002 STATE OF INCORPORATION: FL FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 3000 TAFT ST CITY: HOLLYWOOD STATE: FL ZIP: 33021 BUSINESS PHONE: 954-987-4000 MAIL ADDRESS: STREET 1: 3000 TAFT STREET CITY: HOLLYWOOD STATE: FL ZIP: 33021 FORMER COMPANY: FORMER CONFORMED NAME: HEINICKE INSTRUMENTS CO DATE OF NAME CHANGE: 19860417 4 1 wf-form4_152157173763245.xml FORM 4 X0306 4 2018-03-16 0 0000046619 HEICO CORP HEI, HEI.A 0001031083 MENDELSON ERIC A 825 BRICKELL BAY DRIVE, SUITE 1644 MIAMI FL 33131 1 1 0 0 Co-President Option (Right to purchase Common Stock) 13.7233 2020-09-13 Common Stock 305176.0 305176 D Option (Right to purchase Common Stock) 19.9189 2021-09-12 Common Stock 244141.0 244141 D Option (Right to purchase Common Stock) 26.7622 2023-06-10 Common Stock 97656.0 97656 D Option (Right to purchase Common Stock) 37.088 2025-06-08 Common Stock 78125.0 78125 D Option (Right to purchase Common Stock) 31.1872 2025-12-14 Common Stock 78125.0 78125 D Option (Right to purchase Common Stock) 56.2048 2027-03-17 Common Stock 156250.0 156250 D Option (Right to purchase Class A Common Stock) 19.3126 2023-06-10 Class A Common Stock 97656.0 97656 D Option (Right to purchase Common Stock) 88.32 2018-03-16 4 A 0 100000 0 A 2028-03-16 Common Stock 100000.0 100000 D The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 305,176 shares of Common Stock at an exercise price of $13.7233 per share, as adjusted for stock splits and stock dividends. These Options became exercisable on various dates and expire on September 13, 2020. The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 244,141 shares of Common Stock at an exercise price of $19.9189 per share, as adjusted for stock splits and stock dividends. These Options became exercisable on various dates and expire on September 12, 2021. The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 97,656 shares of Common Stock at an exercise price of $26.7622 per share, as adjusted for stock splits and stock dividends. These Options become exercisable on various dates and expire on June 10, 2023. The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 78,125 shares of Common Stock at an exercise price of $37.088 per share, as adjusted for stock splits and stock dividends. These Options become exercisable on various dates and expire on June 8, 2025. The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 78,125 shares of Common Stock at an exercise price of $31.1872 per share, as adjusted for stock splits and stock dividends. These Options become exercisable on various dates and expire on December, 14 2025 The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 156,250 shares of Common Stock at an exercise price of $56.2048 per share, as adjusted for stock splits and stock dividends. These Options become exercisable on various dates and expire on March, 17 2027. The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 97,656 shares of Class A Common Stock at an exercise price of $19.3126 per share, as adjusted for stock splits and stock dividends. These Options become exercisable on various dates and expire on June, 10 2023. These options become exercisable 20% per year over five years from the date of Grant. /s/ Eric A. Mendelson 2018-03-20